Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Jan 30, 2025 | 11.88 | +2.77 |
Oak Valley Bancorp | OVLY | Jan 30, 2025 | 25.98 | -0.08 |
Oak Woods Acquisition | OAKU | Jan 30, 2025 | 11.45 | +0.35 |
Oaktree Acquisition III Life Sciences | OACC | Jan 30, 2025 | 9.98 | 0.00 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Jan 30, 2025 | 10.19 | 0.00 |
Oaktree Capital A Pref | OAK-A | Jan 30, 2025 | 22.68 | +0.04 |
Oaktree Capital Group B Pref | OAK-B | Jan 30, 2025 | 22.00 | -0.59 |
Oaktree Specialty | OCSL | Jan 30, 2025 | 15.84 | +1.15 |
Oatly ADR | OTLY | Jan 30, 2025 | 0.66 | -1.38 |
Oblong | OBLG | Jan 30, 2025 | 3.86 | +1.98 |
Occidental Petroleum | OXY | Jan 30, 2025 | 48.92 | +0.18 |
Ocean Biomedical | OCEA | Jan 30, 2025 | 0.19 | -22.05 |
Ocean Power Technologies | OPTT | Jan 30, 2025 | 0.64 | -4.94 |
Oceaneering International | OII | Jan 30, 2025 | 25.37 | +0.40 |
OceanFirst Financial | OCFC | Jan 30, 2025 | 18.03 | -1.26 |
OceanFirst Pref | OCFCP | Jan 30, 2025 | 25.41 | -0.27 |
OceanPal | OP | Jan 30, 2025 | 1.16 | +2.65 |
Ocugen | OCGN | Jan 30, 2025 | 0.77 | +3.97 |
Ocular Therapeutix | OCUL | Jan 30, 2025 | 7.78 | -0.77 |
Oculis | OCS | Jan 30, 2025 | 22.35 | +0.90 |
Oddity Tech | ODD | Jan 30, 2025 | 46.87 | +2.99 |
Odyssey Marine Exploration | OMEX | Jan 30, 2025 | 0.48 | -9.45 |
Offerpad Solutions A | OPAD | Jan 30, 2025 | 2.34 | +1.30 |
Office Properties | OPI | Jan 30, 2025 | 0.90 | +0.51 |
OFG Bancorp | OFG | Jan 30, 2025 | 43.37 | +0.18 |
OFS Capital | OFS | Jan 30, 2025 | 8.07 | +0.25 |
OFS Credit | OCCI | Jan 30, 2025 | 7.08 | +0.43 |
OFS Credit C Pref | OCCIO | Jan 30, 2025 | 24.89 | +0.69 |
OFS Credit Company Pref F | OCCIM | Jan 30, 2025 | 24.93 | -0.07 |
OFS Credit E Pref | OCCIN | Jan 30, 2025 | 23.93 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.